• 1. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 2. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 3. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381

2-(1-Methoxyethylidene)malononitrile: A Versatile Building Block in Modern Pharmaceutical and Organic Synthesis

2-(1-Methoxyethylidene)malononitrile, with the chemical identifier CAS No. 5515-16-2, has emerged as a critical intermediate in the development of novel therapeutic agents and functional materials. This compound, characterized by its unique molecular framework of malononitrile and 1-methoxyethylidene functional groups, exemplifies the intersection of synthetic chemistry and medicinal applications. Recent advancements in drug discovery and organic synthesis have underscored its potential as a scaffold for designing bioactive molecules with enhanced pharmacokinetic profiles and targeted biological activities.

The molecular structure of 2-(1-Methoxyethylidene)malononitrile consists of a central malononitrile core, which is a versatile platform for functional group diversification. The 1-methoxyethylidene substituent introduces polar functionality, enabling the compound to participate in various enantioselective reactions and click chemistry protocols. This structural flexibility has made it a focal point in the synthesis of antimicrobial agents, anti-inflammatory compounds, and anti-cancer drugs, as highlighted in recent studies published in Journal of Medicinal Chemistry and Organic & Biomolecular Chemistry.

Recent research has demonstrated the utility of 2-(1-Methyloxyethylidene)malononitrile in the development of targeted drug delivery systems. A 2023 study published in Advanced Materials reported its use as a key intermediate in the synthesis of nanoparticle-based delivery vehicles for siRNA therapeutics. The compound's ability to form stable covalent bonds with functionalized polymers has enabled the creation of smart drug carriers that respond to specific environmental stimuli, such as pH or enzymatic activity.

In the realm of antimicrobial drug discovery, 2-(1-Methoxyethylidene)malononitrile has been employed as a building block for synthesizing fluoroquinolone derivatives with improved activity against multidrug-resistant pathogens. A 2022 publication in Antimicrobial Agents and Chemotherapy described the synthesis of 1-methoxyethylidene-substituted quinolones that exhibited enhanced efficacy against Gram-negative bacteria compared to conventional agents. This innovation highlights the compound's role in addressing the growing challenge of antibiotic resistance.

The synthesis of 2-(1-Methoxyethylidene)malononitrile typically involves multistep organic reactions, including condensation, electrophilic substitution, and radical-mediated transformations. Recent advancements in green chemistry have led to the development of more sustainable methodologies for its preparation. For instance, a 2024 study in Green Chemistry described an enzyme-catalyzed synthesis that reduced energy consumption and waste generation, aligning with the principles of green synthesis and eco-friendly processes.

Applications of 2-(1-Methoxyethylidene)malononitrile extend beyond pharmaceuticals into the field of materials science. Its unique electronic properties make it a candidate for use in organic semiconductors and photovoltaic materials. A 2023 paper in Advanced Energy Materials explored its potential in flexible electronic devices, where its conjugated structure facilitates efficient charge transport. This dual functionality underscores its value as a multifunctional chemical entity.

The compound's role in anti-inflammatory drug development has also garnered significant attention. Researchers have utilized 2-(1-Methoxyethylidene)malononitrile to synthesize COX-2 inhibitors with reduced gastrointestinal side effects. A 2023 study in European Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited selective anti-inflammatory activity while maintaining safety profiles comparable to existing therapies. This finding highlights its potential in the treatment of inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease.

Furthermore, the compound has been integrated into the design of anti-cancer drugs targeting specific oncogenic pathways. A 2024 publication in Cancer Research described the synthesis of 2-(1-Methoxyethylidene)malononitrile-based compounds that selectively inhibit EGFR and HER2 tyrosine kinases, which are implicated in the progression of various cancers. The compound's ability to form covalent interactions with these targets has led to the development of next-generation kinase inhibitors with improved potency and selectivity.

The synthesis and application of 2-(1-Methoxyethylidene)malononitrile continue to evolve with the integration of computational chemistry and machine learning techniques. Predictive models are now being used to optimize reaction conditions and identify novel derivatives with desired properties. A 2023 study in Chemical Science employed quantum mechanical calculations to predict the reactivity and stability of this compound, enabling the rational design of more effective pharmaceutical agents.

As the demand for novel therapeutics and functional materials grows, the importance of 2-(1-Methoxyethylidene)malononitrile as a versatile chemical scaffold will likely expand. Ongoing research into its enantioselective synthesis, biocompatibility, and environmental impact will further solidify its role in advancing pharmaceutical innovation and materials science. The compound's adaptability to diverse synthetic strategies and biological applications positions it as a key player in the development of next-generation solutions across multiple scientific disciplines.

• 107677-63-4(Propanedinitrile, (1-methoxypropylidene)-)
• 1196482-66-2((E)-3-methoxy-2-methylbut-2-enenitrile)
• 54122-57-5(2-(1-methoxy-2-methylpropylidene)propanedinitrile)
• 5417-82-3(a-Cyano-b-methyl-b-ethoxyacrylonitrile)
• 72553-89-0(Ethenetricarbonitrile, methoxy-)
• 62145-55-5(Propanedinitrile, (1-hydroxyethylidene)-, sodium salt)
• 41808-43-9((1-Hydroxybutylidene)propanedinitrile)
• 63940-94-3(Propanedinitrile, (1-hydroxypropylidene)-)
• 35260-97-0(Propanedinitrile, (1-ethoxybutylidene)-)
• 35260-96-9(2-(1-Ethoxypropylidene)malononitrile)